Overview
Mild Canavan disease is a less severe form of Canavan disease, a rare inherited condition that affects the brain's white matter. Canavan disease is also known as Canavan-Van Bogaert-Bertrand disease or aspartoacylase deficiency. In the classic (severe) form, children experience significant developmental problems early in life. In the mild form, the disease progresses more slowly and symptoms are less disabling. Mild Canavan disease is caused by changes (mutations) in the ASPA gene, which provides instructions for making an enzyme called aspartoacylase. This enzyme breaks down a chemical called N-acetylaspartic acid (NAA) in the brain. When the enzyme doesn't work properly, NAA builds up and damages the myelin sheath — the protective coating around nerve fibers. In the mild form, the enzyme still has some remaining activity, which is why symptoms are less severe than in the classic form. People with mild Canavan disease may experience speech delays, mild developmental delays, and some learning difficulties. They typically achieve more developmental milestones than those with the severe form. There is currently no cure for Canavan disease, and treatment focuses on managing symptoms and supporting development through therapies such as speech therapy, physical therapy, and educational support. Gene therapy research is ongoing and offers hope for future treatments.
Also known as:
Key symptoms:
Speech delaysMild developmental delaysLearning difficultiesSlightly enlarged head (mild macrocephaly)Mild problems with balance and coordinationElevated N-acetylaspartic acid (NAA) in urineMild changes in brain white matter on MRIDifficulty with fine motor skillsMild muscle tone abnormalities
Clinical phenotype terms (16)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Mild Canavan disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Mild Canavan disease at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Mild Canavan disease.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Mild Canavan disease.
Community
No community posts yet. Be the first to share your experience with Mild Canavan disease.
Start the conversation →Latest news about Mild Canavan disease
No recent news articles for Mild Canavan disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How can we tell if my child has the mild form versus the severe form of Canavan disease?,What therapies should we start right away to support my child's development?,How often should brain MRI scans be done to monitor the condition?,Are there any clinical trials or experimental treatments we should consider?,What educational supports and accommodations should we request at school?,Should other family members be tested as carriers?,What is the long-term outlook for my child's independence and quality of life?
Common questions about Mild Canavan disease
What is Mild Canavan disease?
Mild Canavan disease is a less severe form of Canavan disease, a rare inherited condition that affects the brain's white matter. Canavan disease is also known as Canavan-Van Bogaert-Bertrand disease or aspartoacylase deficiency. In the classic (severe) form, children experience significant developmental problems early in life. In the mild form, the disease progresses more slowly and symptoms are less disabling. Mild Canavan disease is caused by changes (mutations) in the ASPA gene, which provides instructions for making an enzyme called aspartoacylase. This enzyme breaks down a chemical calle
How is Mild Canavan disease inherited?
Mild Canavan disease follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Mild Canavan disease typically begin?
Typical onset of Mild Canavan disease is childhood. Age of onset can vary across affected individuals.